InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-29.2%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Rabinowitz Michael, Responsable Commercial. Officer active across 1 company, notably Oramed Pharmaceuticals INC.. In total, 6 disclosures have been published. Activity tracked since 4 August 2021. The latest transaction was disclosed on 28 December 2021 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
19,000 sharesCommon StockSEC:0001213900-22-000814
19,000 sharesCommon StockSEC:0001213900-22-000814:0
9,532 shares@ US$12.9846.3% of flowCommon StockSEC:0001213900-21-068230
9,532 shares@ US$12.980.098% mcap50.0% of flowCommon StockSEC:0001213900-21-068230:0
100,000 shares0Common StockSEC:0001213900-21-040761:0
100,000 shares0Common StockSEC:0001213900-21-040761
6 of 6 declarations
About Rabinowitz Michael
Michael Rabinowitz is the Chief Commercial Officer at ORAMED PHARMACEUTICALS INC. He is responsible for managing the company's sales and business development. His expertise in commercial strategy is essential to support growth and optimize financial results. Michael also plays a key role in establishing strategic partnerships and expanding into new markets.
